Weiss Lawrence Martin 4
4 · NEOGENOMICS INC · Filed Mar 3, 2020
Insider Transaction Report
Form 4
Weiss Lawrence Martin
Chief Scientific Officer
Transactions
- Award
Common Stock
2020-03-02+5,824→ 11,717 total - Award
Common Stock
2020-03-02$28.33/sh+37,514$1,062,772→ 37,514 totalExercise: $28.33From: 2021-03-02Exp: 2027-03-02→ Common Stock (37,514 underlying)
Holdings
- 25,000
Stock Option (Right to Buy)
Exercise: $13.87From: 2019-12-12Exp: 2023-12-12→ Common Stock (25,000 underlying) - 36,022
Stock Option (Right to Buy)
Exercise: $19.60From: 2020-03-01Exp: 2024-03-01→ Common Stock (36,022 underlying)
Footnotes (3)
- [F1]On December 12, 2018, Dr. Weiss was granted 25,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
- [F2]On March 1, 2019, Dr. Weiss was granted 36,022 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F3]On March 2, 2020, Dr. Weiss was granted 37,514 stock options. These options vest ratably over the first four anniversary dates of the grant date.